Bayer / VWD / HTC / Baxter / Pfizer / Grifols / National Hemophilia Foundation 2013 Nursing Working Group / /
Country
United States / /
Event
Product Issues / /
IndustryTerm
treatment of bleeding disorders / infusion site / joint disease prevention / particular product / treatment of diabetes / factor products / manufacturing process / ultra-pure products / plasma manufacturing process / web site www.hemophilia.org / coagulation products / Hemophilia Treatment / hemophilia management / generation products / non-factor product / plasma-derived blood products / resuscitation equipment / therapeutic products / Treatment of Hemophilia / /
MedicalCondition
SIADH-like syndrome / Hepatitis A / allergic reaction / moderate hemophilia / HIV / chest pain / headache / seizures / water intoxication / hives / haemophilia / joint disease / Facial flushing / nausea / mild Hemophilia A. Thus DDAVP / anaphylaxis / hepatitis C / hepatitis B / transient headaches / hyponatremia / primary nocturnal enuresis / anaphylactic reactions / Transient hypertension / hemophilia / mild hemophilia A / factor deficiency / hypotension / epistaxis / Hemophilia A / severe hemophilia / shortness of breath / mild hemophilia / venous thrombosis / diabetes / itching / mild chills / allergic reactions / cardiac disease / von Willebrand Disease / mild injuries / dizziness / abdominal cramps / hemophilia A. In / injuries / disorders / /
MedicalTreatment
premedication / elective surgery / surgery / resuscitation / /
Organization
National Hemophilia Foundation / Medical and Scientific Advisory Council / ADMINISTRATION OF FACTOR CONCENTRATES Factor / Centers for Disease Control and Prevention / Repeat administration / /
Position
DOCUMENTATION The nurse / CONCLUSION The nurse / NURSING CONSIDERATIONS The nurse / /
Treatment of Hemophilia A and B Marianne McDaniel, RN INTRODUCTION Treatment for patients with hemophilia and other bleeding disorders has evolved over the past several decades. Replacement of the specific missing plasma